1280197

Abon Pharmaceuticals, LLC — FEI 3007923338

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 6, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chestnut Ridge, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)